NRNP6665Final Exam Test Questions, NR 603 Week 72026 Latest Updated Questions With Answers Success Guide.

NRNP 6665 Final Exam Test Questions, NR 603 Week 7




NRNP 6665 Final Exam Test Questions, NR 603
Week 7 2026 Latest Updated Questions With
Answers Success Guide.
Question 18:
Christine is a 9-year-old female who presents for care
after having been placed in the local foster care system.
She has been in and out of foster care for the last 4 years
after her parents were killed in an automobile accident.
Christine has been placed in a variety of homes and
residential care facilities. The PMHNP recognizes that
Christine is at high risk for: -
Correct Answer -A. Dissociative disorders
B. Post-traumatic stress disorder
C. Impulse-control disorder
D. Attachment disorder

Question 7:
Caylee is a 5-year-old girl who is referred for evaluation by
child protective services. She was recently removed from
her biological family and placed in foster care, as her
home environment was reportedly unsafe due to
conditions of extreme neglect. Her foster mother reports
that Caylee is very quiet and withdrawn and always
appears sad and disinterested in her surroundings;
however, she becomes very irritable when anything
unexpected or unplanned occurs. The foster mother
became very concerned when it appeared that Caylee
was hallucinating. The PMHNP considers that: -
Correct Answer -A. Caylee is at high risk for suicide and
precautions should be taken
B. The hallucinations are consistent with brief psychotic
disorder or schizophrenia
C. The history and reported symptoms are typical of
depressive disorder in young children



1

,NRNP 6665 Final Exam Test Questions, NR 603 Week 7



D. This is a common situation when prepubertal children
are removed from the biological parents regardless of how
dysfunctional they are

Question 2:
Debi is a 15-year-old girl who is currently being treated for
depression. Her parents have been very proactive and
involved in her care, and Debi has achieved remission 2
months after beginning treatment with a combination of
pharmacotherapy and cognitive behavioral therapy. While
counseling Debi's parents about important issues in
management, the PMHNP advises that: -
Correct Answer -A. There is a > 50% likelihood that Debi's
younger sibling will develop depressive symptoms
B. The mean length of major depressive episode in
adolescents is 4 months
C. 20 to 40% of adolescents who have major depressive
disorder will develop bipolar I within 5 years
D. Adolescent-onset depression typically need long-term
pharmacologic management to prevent relapses

Agomelatine -
Correct Answer -Brand: Valdoxan
-Melatonin multimodal (Mel-MM)
-Agonist at melatonergic 1 and melatonergic 2 receptors
-Antagonist at 5HT2C receptors
-Not FDA approved: Rx for Depression, Generalized
anxiety disorder
-Initial 25 mg/day at bedtime; after 2 weeks can increase
to 50 mg/day at bedtime

Amitriptyline (Elavil) -
Correct Answer -Tricyclic antidepressant.

Aripiprazole (Abilify) -
Correct Answer -Treatment for depression. Atypical
antipsychotic. "Dopamine stabilizer". Dopamine receptor


2

,NRNP 6665 Final Exam Test Questions, NR 603 Week 7



antagonist in high concentration and also stimulates
increase of dopamine in low concentrations. Side effects:
insomnia, akathisia.

Brexpiprazole (Rexulti) -
Correct Answer -Treatment for depression. Atypical
antipsychotic

Bupropion (Wellbutrin) -
Correct Answer -Antidepressant and smoking cessation
aid, It can treat depression and help people quit smoking.
It can also prevent depression caused by seasonal
affective disorder (SAD).

Citalopram (Celexa) -
Correct Answer -Antidepressant, SSRI: 20-40 mg qd.

Clomipramine (Anafranil) -
Correct Answer --Serotonin reuptake inhibitor (S-RI)
-Tricyclic antidepressant (TCA)
-Parent drug is a potent serotonin reuptake inhibitor
Active metabolite is a potent norepinephrine/noradrenaline
reuptake inhibitor
-Increases serotonergic neurotransmission by blocking the
serotonin reuptake pump (transporter), -Desensitization of
serotonin receptors, especially serotonin 1A receptors
-Increases noradrenergic neurotransmission by blocking
the norepinephrine reuptake pump (transporter), -
Desensitization of beta adrenergic receptors
-Dopamine is inactivated by norepinephrine reuptake in
the frontal cortex
-Lacks dopamine transporters
-Increases dopamine neurotransmission in this part of the
brain
**FDA Approved for Pediatrics in tx Obsessive-compulsive
disorder (OCD) (ages 10 and older)



3

, NRNP 6665 Final Exam Test Questions, NR 603 Week 7



*Off-Label for Pediatric Use: Depression, Severe and
treatment-resistant, depression, Cataplexy syndrome,
Anxiety, Insomnia,
Neuropathic pain/chronic pain
-Full therapeutic benefits may take 2-8 weeks
-Dosing: in Peds/Adolescents/Adults:
100-250mg/day

Cyamemazine (Tercian) -
Correct Answer -Treatment for depression.
-Known as cyamepromazine
-Typical antipsychotic drug of the phenothiazine class.
-Treatment for schizophrenia
and psychosis-associated
anxiety
-Behaves like an atypical
antipsychotic, due to its
potent anxiolytic effects (5-HT2C) and lack of
extrapyramidal side effects (5-HT2A).
-Conventional antipsychotic (neuroleptic, phenothiazine,
dopamine 2 antagonist, serotonin dopamine antagonist)
-Commonly Prescribed for (not FDA approved):
-Schizophrenia
-Anxiety associated with psychosis (short-term)
-Anxiety associated with nonpsychotic disorders,
including mood disorders and personality disorders (short-
term)
-Severe depression
-Bipolar disorder
-Other psychotic disorders
-Acute agitation/aggression (injection)
-Benzodiazepine withdrawal

Desiprimine (Norpramine) -
Correct Answer -Treats depression
Brand: Norpramin
-TCA


4